Market: NASD |
Currency: USD
Address: 260 Charles Street
OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.
📈 OptimizeRx Corporation Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$19.00
-
Upside/Downside from Analyst Target:
17.72%
-
Broker Call:
12
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
25-50%
-
Net Income Growth Range (1Y):
25-50%
-
Revenue Growth Range (1Y):
25-50%
-
Upcoming Earnings Date:
2025-11-13
-
EPS Estimate:
0.04
💰 Dividend History
Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
2018 |
- |
$0.333333 |
- |
2018-05-14 |
- |
Stock split |
Total Amount for 2018: $0.333333 |
📅 Earnings & EPS History for OptimizeRx Corporation
Date | Reported EPS |
---|
2025-11-12 (estimated upcoming) | - |
2025-08-07 | 0.24 |
2025-05-12 | 0.08 |
2025-03-12 | 0.3 |
2024-11-13 | 0.12 |
2024-08-08 | 0.02 |
2024-05-14 | -0.11 |
2024-04-18 | 0.26 |
2023-11-06 | -0.17 |
2023-08-14 | -0.01 |
2023-05-10 | -0.09 |
2023-03-08 | 0.25 |
2022-11-08 | 0.07 |
2022-08-09 | 0.04 |
2022-05-04 | -0.01 |
2022-02-24 | 0.22 |
2021-11-09 | 0.09 |
2021-08-04 | 0.1 |
2021-05-06 | 0.03 |
2021-02-24 | 0.16 |
2020-11-09 | 0.06 |
2020-08-05 | 0.02 |
2020-05-04 | -0.06 |
2020-02-27 | -0.03 |
2019-11-05 | -0.05 |
📰 Related News & Research
No related articles found for "optimizerx corporation".